IQVIA™ Real-World Insights Bibliography

Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Author(s):  Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations(s): 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Author(s):  Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations(s): IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan: A Population Study Based on Nhrid
Author(s): Chung C1,Tai TA2,Chou KP2
Affiliations(s): 1-Mackay Medical College , New Taipei City , Taiwan 2-IMS Health Taiwan , Taipei , Taiwan
Publication(s):  Value Health. 2016 nov; 19(7): A842
Document Type(s): Abstract,
Countries: Taiwan,
Click here for the abstract
C:
Y:
Mental health,
2016
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis.
Author(s): Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7
Affiliations(s): 1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del RocĂ­o, US, CSIC), Seville, Spain.
Publication(s):  Lung Cancer. 2014 Aug;85(2):230-8
Document Type(s): Article,
Countries: China, Germany, Hong Kong, Spain, Taiwan, UK,
Click here for the abstract
C:
Y:
Oncology,
2014
  L:
A:
English
Meta analysis,
  Add to report
 
 
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Author(s): Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations(s): 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publication(s):  ISPOR Europe 2013 Annual meeting
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK,
Click here for the abstract
C:
Y:
Oncology,
2013
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Current situation of oral anticancer treatments use in France: the ACTOR Study.
Author(s): Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations(s): 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publication(s):  ISPOR Europe 2013 Annual meeting
Document Type(s): Abstract,
Countries: China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK,
Click here for the abstract
C:
Y:
Oncology,
2013
  L:
A:
English
  Add to report
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Burden of illness,
  Add to report
 
 
Impact of anti-viral treatment on the economic burden of chronic Hepatitis B in Taiwan
Author(s): Chen PJ1, Chen CJ2, Yang HI3, McLeod E4, Heatley R5
Affiliations(s): 1 National Taiwan University Hospital, Taipei, Taiwan 2 Academia Sinica, Taipei, Taiwan 3 China Medical University Hospital, Taichung City, Taiwan 4 IMS Health, London, UK 5 Complete Medical Group, Macclesfield, Cheshire, UK
Publication(s):  ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan, September 2nd ? 4th 2012
Document Type(s): Poster,
Countries: Taiwan,
Click here for the abstract
C:
Y:
Infectious disease,
2012
  L:
A:
English
Budget impact,
  Add to report
 
 
Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas.
Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5
Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK
Publication(s):  European Respiratory Review 2006; 15:(98): 24-29
Document Type(s): Manuscript in preparation,
Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam,
C:
Y:
Respiratory disease,
2006
  L:
A:
English
Cost of illness,
  Add to report